Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR)

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class: Equity / Ordinary Shares, $0.0001 par value
Shares outstanding: 172,779,139
Number of holders: 162
Total 13F shares, excl. options: 61,353,441
Shares change: +2,340,629
Total reported value, excl. options: $2,685,754,087
Value change: +$108,883,080
Put/Call ratio: 80%
Number of buys: 94
Number of sells: -66
Price: $43.89

Significant Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) as of Q3 2024

221 filings reported holding GPCR - Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value as of Q3 2024.
Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) has 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 61,353,441 shares of 172,779,139 outstanding shares and own 36% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (7,769,771 shares), FMR LLC (6,128,444 shares), JANUS HENDERSON GROUP PLC (3,956,878 shares), Capital Research Global Investors (3,530,450 shares), Driehaus Capital Management LLC (2,526,430 shares), FEDERATED HERMES, INC. (2,411,600 shares), BVF INC/IL (2,238,986 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,084,687 shares), RA CAPITAL MANAGEMENT, L.P. (1,896,772 shares), and Capital International Investors (1,516,022 shares).
This table shows the top 162 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.